骨生长刺激器市场规模、份额和增长分析：按应用、按最终用户、按产品、按地区 - 行业预测，2024-2031 年

Bone Growth Stimulators Market Size, Share, Growth Analysis, By Application, By End User, By Product, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球骨生长刺激剂市场规模预估为21亿美元，预测期间（2024-2031年）复合年增长率为4.9%，从2023年的22亿美元增至2031年的32.3亿美元。 10,000,000 美元。

骨骼生长刺激已被广泛认为是一种补充疗法，特别是有助于骨折癒合。当骨折无法自行癒合时，通常会使用这些刺激器。世界各地骨折和运动相关伤害的发生率不断增加，推动了对这些设备的需求增加。根据国家脊髓损伤统计中心 (NSCISC) 的数据，美国每年每百万人中约有 54 例新增脊髓损伤。美国国家生物技术资讯中心最近的一份报告估计，在全球整体，每年有 25 万至 50 万人遭受脊髓损伤。骨生长刺激技术极大地促进了整形外科手术的发展，并引发了大量关于骨生成激素的临床研究。这些刺激器广泛应用于脊椎融合、牙科、颚颜面外科、骨折修復等各个领域。由于骨关节炎和退化性骨疾病的盛行率不断上升，骨生长刺激剂市场正在扩大。此外，越来越多地采用富含血小板的血浆和骨生成激素有助于改善癒合结果。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Zimmer Biomet Holdings, Inc.（US）
Stryker Corporation（US）
Medtronic plc（Ireland）
Orthofix Medical Inc.（US）
Bioventus LLC（US）
Arthrex, Inc.（US）
Smith & Nephew plc（UK）
Elizur Corporation（US）
Isto Biologics（US）
Ossatec Benelux BV（Netherlands）
Terumo Corporation（Japan）
Bioventus LLC（US）
Ember Therapeutics（US）
Isto Biologics（US）
Ossatec Benelux BV（Netherlands）
BONESUPPORT AB（Sweden）
Regen Lab SA（Switzerland）
Cerapedics, Inc.（US）
Orthocell Ltd.（Australia）
Alphatec Spine, Inc.（US）
Bone Therapeutics SA（Belgium）
EndoStim, Inc.（US）

简介目录

Product Code: SQMIG35A2314

Global Bone Growth Stimulators Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.20 billion in 2023 to USD 3.23 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

Bone growth stimulation has become a widely recognized complementary therapy, especially for aiding the healing of bone fractures. These stimulators are commonly used when fractures fail to heal on their own. The growing incidence of bone fractures and sports-related injuries worldwide is driving increased demand for these devices. According to the National Spinal Cord Injury Statistical Center (NSCISC), approximately 54 new cases of spinal cord injury occur per million people in the United States each year. Globally, a recent report from the National Centre for Biotechnology Information estimates that between 250,000 and 500,000 individuals suffer from spinal cord injuries annually. Bone growth stimulation technology has significantly advanced orthopedic surgeries, leading to numerous clinical studies on bone morphogenetic proteins. These stimulators are widely utilized in various fields, including spinal fusion, dentistry, maxillofacial surgery, and fracture repair. The market for bone growth stimulators is expanding due to the rising prevalence of osteoarthritis and degenerative bone conditions. Additionally, the growth of the market is supported by the increasing adoption of platelet-rich plasma and bone morphogenetic proteins, which contribute to enhanced healing outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Growth Stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Growth Stimulators Market Segmental Analysis

The global bone growth stimulators market is segmented based on product type, application, end user and region. Based on product type, the market is segmented into bone growth stimulation devices {external bone growth stimulators (ultrasonic bone growth stimulators, and implanted bone growth stimulators)}, bone morphogenetic proteins, and platelet-rich plasma. Based on application, the market is segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral & maxillofacial surgeries, and others. Based on end user, the market is segmented into hospitals & ambulatory surgical centers, home care settings, and academic & research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Bone Growth Stimulators Market

The increasing incidence of orthopedic conditions, including fractures, delayed unions, non-unions, and osteoporosis-related fractures, is a major factor driving the bone growth stimulators market. As the population ages and the frequency of orthopedic issues rises, the need for effective bone growth solutions is growing. With the aging demographic and the corresponding rise in orthopedic conditions, there is a heightened demand for bone growth stimulators. This growing need reflects the broader trend of addressing and managing various bone health challenges that come with advancing age.

Restraints in the Global Bone Growth Stimulators Market

Although bone growth stimulators are typically deemed safe, there are potential side effects and risks to be aware of. These may include skin irritation, allergic reactions, and discomfort during the treatment process. Such concerns about possible adverse effects might discourage some patients and healthcare providers from opting for bone growth stimulators. The potential for these side effects can influence decisions regarding their use in managing bone health and healing.

Market Trends of the Global Bone Growth Stimulators Market

Currently, the bone growth stimulators industry is being shaped by several significant developments. A notable trend is the growing demand for patient-friendly and minimally invasive treatments. Bone growth stimulators are increasingly favored by both healthcare providers and patients as they offer a less intrusive alternative to traditional surgical methods, promoting bone healing effectively. This preference for less invasive options is especially evident in the treatment of orthopedic conditions such as spinal fusion and fractures. The shift towards bone growth stimulators reflects a broader movement towards more accessible and less disruptive treatment solutions in the field of orthopedic care.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Supply Chain Analysis
Value Chain Analysis
Patent Analysis
Trade Analysis
Pricing Analysis
Startup Analysis

Global Bone Growth Stimulators Market by Product

Market Overview
Bone Growth Stimulation Devices
- External Bone Growth Stimulators
- Pulsed electromagnetic field devices
- Combined magnetic field devices
- Capacitive coupling devices
- Ultrasonic Bone Growth Stimulators
- Implanted Bone Growth Stimulators
Bone Morphogenetic Proteins
Platelet-Rich Plasma

Global Bone Growth Stimulators Market by Application

Market Overview
Spinal Fusion Surgeries
Delayed Union & Non-Union Bone Fractures
Oral & Maxillofacial Surgeries
Others

Global Bone Growth Stimulators Market by End-User

Market Overview
Hospitals & Ambulatory Surgical Centers
Home Care Settings
Academic & Research Institutes

Global Bone Growth Stimulators Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elizur Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isto Biologics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ember Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isto Biologics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BONESUPPORT AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regen Lab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerapedics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthocell Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alphatec Spine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bone Therapeutics SA (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EndoStim, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments